Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Multistimulation Group Therapy for Alzheimer's Disease [NA]
The clinical trial evaluating Multistimulation Group Therapy for Alzheimer's Disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 safety and efficacy study of AC-3933 in adults with mild to moderate Alzheimer's disease has completed, with results posted in 2013.
-
FDA approval · 2013-06-27FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for rivastigmine submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating repetitive transcranial magnetic stimulation for apathy in Alzheimer's disease; status is currently unknown.
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease. [NA]
Clinical trial investigating alpha-synuclein in CSF to differentiate Alzheimer's disease from Lewy body dementia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-06-11Clinical Trial Update: Biomarker Study to Diagnose Alzheimer's Disease [NA]
This entry reports an ongoing biomarker study sponsored by Seoul National University Hospital aimed at diagnosing Alzheimer's disease, inclu…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease [NA]
Clinical trial assessing deep brain stimulation of the nucleus basalis of Meynert to address cognitive deficits in light-to-moderate Alzheim…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease [Phase 2]
Phase 2 study of an NMDA-enhancing agent for Alzheimer's disease and mild cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Mirtazapine for Sleep Disorders in Alzheimer's Disease [Phase 3]
A Phase 3 clinical trial evaluating mirtazapine for sleep disorders in Alzheimer's disease; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption [Phase 1]
Phase 1 trial comparing the bioavailability of E2609 tablets to capsules and assessing the effect of food on absorption in Alzheimer's disea…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects [Phase 1]
This is a Phase 1 randomized, double-blind, placebo-controlled, sequential ascending, single-dose study by Eisai Inc. to evaluate the safety…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Computer-Based Training for Mild Alzheimer's Disease [Phase 1]
A Phase 1 trial evaluating computer-based training for individuals with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Apathy in Dementia Methylphenidate Trial (ADMET) [Phase 2]
Phase 2 trial investigating methylphenidate for apathy in Alzheimer's disease completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
The NAC-003 P.L.U.S. Program clinical trial sponsored by Pamlab, Inc. has completed, evaluating effects in mild cognitive impairment, early …
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Antipsychotic Discontinuation in Alzheimer's Disease [Phase 4]
Phase 4 clinical trial update on discontinuation of an antipsychotic in Alzheimer's disease with psychotic symptoms; results have been poste…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Identifying Potential Effects of Liraglutide on Degenerative Changes [NA]
A completed clinical trial from the University of Aarhus explored potential effects of liraglutide on degenerative changes in Alzheimer's di…
-
CLINICAL_TRIALS research · 2013-04-16Clinical Trial Update: A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease
A completed survey-based clinical trial update examining how treatments and outcomes are managed in patients diagnosed with Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease
A completed clinical trial update suggests pregnenolone sulfate could serve as an early biomarker for memory loss in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients [Phase 4]
Phase 4 study at Duke University evaluating functional brain imaging as a measure of medication response in mild Alzheimer's disease has bee…
-
EMA withdrawal · 2013-04-10EMA Application withdrawn: Memantine FGK (memantine) — FGK Representative Service GmbH
The EMA application for Memantine FGK (memantine) has been withdrawn by FGK Representative Service GmbH.
-
FDA label_change · 2013-04-04FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA notice of a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc., indicating an update to the product …
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users [Phase 1]
Pfizer conducted a Phase 1 study to evaluate the abuse potential of single oral doses of dimebon (latrepirdine) in healthy recreational poly…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) [Phase 1]
This report documents the completion of a Phase 1 safety and tolerability trial in patients with mild to moderate Alzheimer's disease. The s…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: TMS Stimulation and Cognitive Training in Alzheimer Patients [Phase 1]
Phase 1 trial evaluating transcranial magnetic stimulation (TMS) with cognitive training for patients with mild-to-moderate Alzheimer diseas…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) [Phase 2]
This clinical trial update reports results from an observational study assessing cognitive outcomes in individuals who previously underwent …